한글목차

외과용 스테이플러 시장 규모는 예측 기간 동안 7.2%의 CAGR로 확대되어 2024년 51억 5,000만 달러에서 2029년 72억 9,000만 달러에 달할 것으로 예상됩니다.

최소침습 수술에 대한 수요 증가는 수술, 특히 복강경 및 내시경 수술에서 수술용 스테이플러의 채택이 증가하는 주요 요인입니다. 최소침습 수술은 개복 수술에 비해 몇 가지 장점이 있기 때문에 선호되고 있습니다. 절개 부위 축소, 통증 최소화, 입원 기간 단축, 회복 시간 단축 등 여러 가지 장점이 있습니다. 환자의 치료 결과 개선, 합병증 및 감염률 감소, 흉터 감소 등이 특징입니다. 수술용 스테이플러, 특히 직선형 스테이플러와 원형 스테이플러는 앞서 설명한 시술에 매우 유용합니다.

스테플러는 주변 조직의 파괴가 거의 없이 빠르고 확실하며 균일한 조직 폐쇄가 가능합니다. 스테이플 링은 기존의 봉합사처럼 단계적으로 봉합 할 필요가 없으므로 수술에 대한 접근을 단축하고 시간을 절약하며 조직 정렬을 용이하게합니다. 예를 들어 복강경 수술의 경우 시야와 조작성이 제한적이기 때문에 제한된 공간에서 안전하게 닫을 수 있는 스테이플러가 매우 인기가 있습니다. 비만 수술, 대장 수술 및 부인과 수술은 그 수가 증가하고 있으며, 최소침습적 절차의 도움으로 점점 더 많이 수행되고 있기 때문에 외과용 스테이플러가 필요합니다. 의료진은 환자를 최대한 돌보고 상대적으로 긴 회복 기간을 통해 비용을 관리하기 위해 계속 추진하고 있기 때문에 스테이플러는 점차 현대 수술에서 대량 채택을 촉진하는 봉합사에 자리를 내어줄 것으로 보입니다.

리니어 스테이플러는 정밀도와 제어력이 뛰어나며, 정밀도가 최우선시 되어야 하는 섬세한 조직을 포함하는 시술에 매우 유용합니다. 이 접근법은 확실한 조직 폐쇄가 가능하며, 출혈, 누출, 감염과 같은 합병증으로 인해 팔꿈치에 공간이 거의 남지 않습니다. 따라서 소화기, 흉부, 비만 수술과 같이 미세한 제어가 우수한 결과를 얻기 위해 필수적인 수술에서 전문적인 기술이 될 수 있습니다. 봉합사들은 속도, 단순성 및 효율성 때문에 선형 스테이플러를 선호합니다. 문합은 숙련된 외과 의사의 손에서 누출 없이 즉각적으로 이루어지기 때문에 시간적으로나 위험 측면에서 효율적입니다.

수동 스테이플러는 정확성, 편의성 및 친숙함을 제공하기 때문에 외과 의사들이 선호합니다. 조직 근사시 즉각적인 촉각 피드백을 통해 외과의사는 긴장감을 얻을 수 있으며, 특히 섬세한 케이스에서 스테이플 배치를 최적화하기 위해 적절한 시술 조정을 할 수 있습니다. 이러한 실습 제어는 조직의 완벽한 정렬과 밀접한 폐쇄를 보장하고 부적절한 치유 및 조직 누출과 관련된 합병증을 줄입니다. 외과 의사들은 수동 스테이플러의 직관적 인 조작감을 좋아하고 동력 장비와 같은 복잡함이없고 안정적인 성능을 제공합니다. 편리함과 정확성이 결합되어 많은 외과 의사들이 수동 스테이플러를 수술용 스테이플러로 자신있게 사용하게 되었습니다.

이 보고서는 세계 외과용 스테이플러 시장을 조사하여 유형별, 기술별, 사용법별, 용도별, 응용 분야별, 최종사용자별, 지역별 동향, 시장 진입 기업 개요 등을 정리한 보고서입니다.

목차

제1장 소개

제2장 조사 방법

제3장 주요 요약

제4장 주요 인사이트

제5장 시장 개요

• 소개
• 시장 역학
• 업계 동향
• 기술 분석
• 공급망 분석
• 밸류체인 분석
• 무역 분석
• Porter's Five Forces 분석
• 주요 이해관계자와 구입 기준
• 규제 상황
• 특허 분석
• 가격 분석
• 2024-2025년의 주요 회의와 이벤트
• 생태계 분석
• 고객의 비즈니스에 영향을 미치는 동향/혼란
• AI/생성형 AI가 외과용 스테이플러 시장에 미치는 영향
• 투자와 자금 조달 시나리오
• 사례 연구 분석
• 인접 시장 분석

제6장 외과용 스테이플러 시장(유형별)

• 소개
• 선형 스테이플러
• 원형 스테이플러
• 스킨 스테이플러
• 기타

제7장 외과용 스테이플러 시장(기술별)

• 소개
• 수동 스테이플러
• 전동 스테이플러

제8장 외과용 스테이플러 시장(사용법별)

• 소개
• 일회용 스테이플러
• 재이용 스테이플러

제9장 외과용 스테이플러 시장(용도별)

• 소개
• 복부·골반 외과수술
• 일반외과
• 심장·흉부외과
• 정형외과
• 기타

제10장 외과용 스테이플러 시장(최종사용자별)

• 소개
• 병원
• 외래 수술 센터
• 기타

제11장 외과용 스테이플러 시장(지역별)

• 소개
• 북미
  • 북미의 거시경제 전망
  • 미국
  • 캐나다
• 유럽
  • 유럽의 거시경제 전망
  • 독일
  • 영국
  • 프랑스
  • 이탈리아
  • 스페인
  • 기타
• 아시아태평양
  • 아시아태평양의 거시경제 전망
  • 중국
  • 일본
  • 인도
  • 호주
  • 한국
  • 기타
• 라틴아메리카
  • 라틴아메리카의 거시경제 전망
  • 브라질
  • 멕시코
  • 기타
• 중동 및 아프리카
• GCC 국가

제12장 경쟁 상황

• 소개
• 매출 분석, 2019-2023년
• 시장 점유율 분석, 2023년
• 기업 평가 매트릭스 : 주요 진출 기업, 2023년
• 기업 평가 매트릭스 : 스타트업/중소기업, 2023년
• 기업 평가와 재무 지표
• 브랜드/제품 비교
• 외과용 스테이플러 시장 : 연구개발비
• 경쟁 시나리오

제13장 기업 개요

• 주요 진출 기업
  • MEDTRONIC
  • JOHNSON & JOHNSON SERVICES, INC.(ETHICON, INC.)
  • LEPU MEDICAL TECHNOLOGY(BEIJING) CO., LTD.
  • INTUITIVE SURGICAL OPERATIONS, INC.
  • 3M
  • CONMED CORPORATION
  • B. BRAUN SE
  • SMITH+NEPHEW
  • WELFARE MEDICAL LTD.
  • REACH SURGICAL
  • MERIL LIFE SCIENCES PVT. LTD.
  • XNY MEDICAL
  • PURPLE SURGICAL
  • FRANKENMAN INTERNATIONAL LTD.
  • LEXINGTON MEDICAL CENTER
• 기타 기업
  • NINGBO VERYKIND MEDICAL DEVICE CO., LTD.
  • WASTON MEDICAL CORPORATION
  • SUTURE PLANET
  • DOLPHIN SUTURES
  • TOUCHSTONE INTERNATIONAL MEDICAL SCIENCE CO., LTD.
  • NEWGEN SURGICAL
  • EDGES MEDICARE PRIVATE LIMITED
  • GOLDEN STAPLER SURGICAL CO., LTD.
  • VICTOR MEDICAL INSTRUMENTS CO., LTD.
  • VOLKMANN MEDIZINTECHNIK GMBH

제14장 부록

영문목차

The surgical staplers market is projected to reach USD 7.29 Billion by 2029 from USD 5.15 Billion in 2024 at a CAGR of 7.2% during the forecast period. Increased demand for minimally invasive procedures is the leading factor for the growing adoption of surgical staplers during surgeries, especially laparoscopic and endoscopic ones. A minimally invasive technique is favored because it offers several advantages over open surgeries; these include smaller cuts, pain minimization, shorter periods of stay in hospitals, and quicker recovery times. Improved outcomes of patient care and reduced complication and infection rates as well as scarring characterize outcomes. Surgical staplers, particularly linear and circular staplers, are very useful for the procedures described. They offer fast, secure, and uniform tissue closure with almost minimal disruption to the surrounding tissues. Stapling does not have to be staged as in a conventional suture; it shortens the approach to surgery, saves time, and affords easier tissue alignment. For instance, in laparoscopic surgeries, visibility and maneuverability being limited, staplers are highly sought after because they enable safe closures within confined spaces. Bariatric, colorectal, and gynecologic procedures are being increased in number and are increasingly being performed with the aid of minimally invasive techniques and therefore, require surgical staplers. As medical professionals continue to push for maximum patient care and control of cost attributed to recovery periods, which are relatively long, staplers gradually give way to sutures that promote mass adoption in modern surgeries.

"The linear surgical staplers segment is accounted for the largest share of surgical staplers market."

Linear staplers are valued highly for their precision and control and are very useful in procedures involving delicate tissues, where accuracy has to be at the top. With this approach, there is reliable tissue closure, and little elbow space for complications like bleeding, leakage, or infection.It is thus a specialty bonus for procedures like gastrointestinal, thoracic, and bariatric surgeries, where fine control is vital for excellent outcomes. Suturers like linear staplers for their speed, simplicity, and efficiency. Anastomoses are accomplished in the jiffy-with no leaks-under the fingers of the skilled surgeon, hence making their procedures both time and risk-effective.

"Manual segment holds the largest market share of surgical staplers market."

Manual staplers are favorites of surgeons because they provide precision, simplicity, and familiarity. The immediate tactile feedback made during tissue approximation allows the surgeon to achieve the sense of tension, which will allow him to make the appropriate adjustment of technique on optimizing staple placement, especially in delicate cases. These hands-on controls guarantee perfect alignment of tissues and tight closure for fewer complications associated with improper healing of tissues or leakage. Surgeons like the intuitive feel of manual staplers, with consistent performance that is not so complex as powered devices. Ease combined with precision has convinced many surgeons to rely confidently on manual staplers as their staple for operations.

"Disposable segment holds the largest market share in the global surgical staplers market"

Although the initial cost of disposable staplers happens to be higher than that of re-usable staplers, the latter could actually save the facility quite a good sum in the long term by eliminating the costs incurred on sterilization and maintenance. Reusable staplers need to be cleaned and sterilized quite frequently and even serviced at regular intervals so that they remain in a functional and safe condition, increasing the operational expenses of healthcare facilities. Disposable staplers, on the other hand, come presterilized and ready for use: that is less labor, fewer resources are required for cleaning and maintenance. This approach may save more time and even cross-contamination, thereby justifying more expensive costs at the outset, improving overall efficiency and safety.

"Abdominal & pelvic surgery segment accounted for the largest market share in the global surgical staplers market and expected to grow at the highest CAGR during the forecast period."

The volume of abdominal surgeries, among them appendectomies, bowel resections, and pelvic surgery, is creating high demand for surgical staplers. Such procedures require accurate and efficient closure of tissues to ensure the desired outcome without any complications. Surgical staplers ensure uniform and secure closures and are essential instruments in such abdominal surgeries. This will be greatly prized in high-pressurized surgery environments due to their ability to diminish operative time and advance surgical accuracy. Growing cases of appendicitis and colorectal diseases, as well as gynecological disorders, are also bound to heighten further the demand for reliable operative stapling devices.

"Hospitals segment accounted for the largest market share in the global surgical staplers"

With expanding hospitals networks around the world, particularly in emerging markets, surgical volumes are increasing steeply along with demand for surgical staplers. It is primarily now that healthcare infrastructure is being improved and access to care is being expanded for a larger population that is forcing more patients into surgical treatments, and the need for reliable and effective surgical tools increases with them. As such, the emerging markets are also witnessing investments in advanced medical technologies to assist in complicated procedures. These would, therefore, further fuel the adoption of surgical staplers. Staplers have been considered to improve surgical accuracy, reduce operative time, and enhance outcomes for patients; thus, they form an essential part of modern surgical practice the world over.

"North America to witness the substantial growth rate during the forecast period."

The surgical staplers market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East & Africa and GCC Countries based on the region type. In 2023, the Asia Pacific region is projected to exhibit the highest CAGR during the forecast period. However, North America accounts for the largest market share of the surgical staplers market in 2023. North America specifically has high volumes of surgery in specialties like general surgery, orthopedics, and bariatric surgery, which are among the biggest drivers for surgical staplers. Overall advanced healthcare infrastructure and stress on state-of-art medical practices in the region also well support broad-scale adoption of the products. With such innovative houses as Medtronic and Johnson & Johnson that are persistently working on designing newer surgical stapling variants with characteristic properties like the introduction of powered mechanisms with real-time feedback systems that would still enhance precision and safety further, this type of development remains in line with the highest demand for minimal invasiveness, and that leads to the market growth with more adoption. North America will always remain on top as it has kept its focus on technologically outperforming surgical stapler application.

A breakdown of the primary participants (supply-side) for the surgical staplers market referred to for this report is provided below:

• By Company Type: Tier 1-45%, Tier 2-30%, and Tier 3-25%
• By Designation: C-level-35%, Director Level-25%, and Others-40%
• By Region: North America-40%, Europe-20%, Asia Pacific-25%, Latin America- 10%, and Middle East and Africa- 3% and GCC Countries- 2%

Prominent players in this market include Medtronic Plc (Ireland), Johnson & Johnson (Ethicon, Inc.) (US), Lepu Medical Technology (Beijing) Co.,Ltd. (China), Intuitive Surgical Inc (US), 3M Company (US), CONMED Corporation (US), B. Braun SE (Germany), Smith+Nephew (UK), Welfare Medical Ltd. (UK), Reach Surgical (China), Meril Life Sciences Pvt Ltd. (India), XNY Medical (China), Purple Surgical (UK), Frankenman International Ltd. (China), Lexington Medical (US), Ningbo Verykind Medical Device Co., Ltd (China), Waston Medical Corporation (China), Suture Planet (India), Dolphin Suture (India), Touchstone International Medical Science Co. Ltd. (China), NewGen Surgical (US), Edges Medicare Private Limited (India), Golden Stapler Surgical Co., Ltd., (China), Victor Medical Instruments Co., Ltd. (China), and Volkmann Medizintechnik GmbH (Germany).

Research Coverage:

The market study covers the surgical staplers market across various segments. It aims at estimating the market size and the growth potential of this market across different segments by type, technology, usability, application, end user and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.

Reasons to Buy the Report

This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.

This report provides insights on:

• Analysis of Market Dynamics: Drivers (technological advancements in surgical staplers, expansion of minimally invasive surgery (mis), rising surgical demand due to chronic diseases and healthcare expansion in emerging markets) restraints (high cost of advanced surgical staplers, risk of complications and device failures, limited adoption in emerging markets) opportunities (integration of surgical staplers with robotic surgery systems, expansion into low-resource settings and development of customizable and smart stapling solutions), and challenges (integration with existing surgical protocols, and navigating diverse regulatory environments)
• Services/Innovations: Detailed insights on upcoming technologies, research & development activities, and new product launches in the surgical staplers market.
• Market Development: Comprehensive information on the lucrative emerging markets, components, demographics, end-user, and region.
• Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the surgical staplers market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the surgical staplers market like Medtronic Plc (Ireland), Johnson & Johnson (Ethicon, Inc.) (US), Lepu Medical Technology (Beijing) Co.,Ltd. (China), Intuitive Surgical Inc (US), and 3M Company (US).

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 SEGMENTS CONSIDERED
  • 1.3.2 INCLUSIONS AND EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
  • 1.3.4 CURRENCY CONSIDERED
• 1.4 STAKEHOLDERS
• 1.5 SUMMARY OF CHANGES
  • 1.5.1 IMPACT OF AI/GEN AI

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Objectives of secondary research
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Objectives of primary research
• 2.2 MARKET SIZE ESTIMATION
  • 2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION
  • 2.2.2 BOTTOM-UP APPROACH
  • 2.2.3 COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS
  • 2.2.4 TOP-DOWN APPROACH
  • 2.2.5 PRIMARY RESEARCH VALIDATION
• 2.3 GROWTH FORECAST ESTIMATION
• 2.4 DATA TRIANGULATION
• 2.5 MARKET RANKING ANALYSIS
• 2.6 STUDY ASSUMPTIONS
• 2.7 RISK ASSESSMENT
• 2.8 RESEARCH LIMITATIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 SURGICAL STAPLERS MARKET OVERVIEW
• 4.2 ASIA PACIFIC: SURGICAL STAPLERS MARKET, BY TYPE AND COUNTRY (2024)
• 4.3 SURGICAL STAPLERS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
• 4.4 SURGICAL STAPLERS MARKET: REGIONAL MIX, 2024-2029
• 4.5 SURGICAL STAPLERS MARKET: DEVELOPED VS. EMERGING MARKETS

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Technological advancements in surgical staplers
    • 5.2.1.2 Increased adoption of minimally invasive surgical techniques over traditional open surgeries
    • 5.2.1.3 Rising incidence of chronic lifestyle-related diseases
    • 5.2.1.4 Growing healthcare sector in emerging economies
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 High cost of advanced surgical staplers
    • 5.2.2.2 Risk of complications and device failures
    • 5.2.2.3 Limited adoption of surgical staplers in emerging markets
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Integration of surgical staplers with robotic surgery systems
    • 5.2.3.2 Increasing availability in low-resource settings
    • 5.2.3.3 Development of customizable and smart stapling solutions
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Integration with conventional surgical protocols and medical practices
    • 5.2.4.2 Presence of diverse regulatory environments across regions
• 5.3 INDUSTRY TRENDS
  • 5.3.1 SHIFT TOWARD DISPOSABLE STAPLERS FOR INFECTION CONTROL
• 5.4 TECHNOLOGY ANALYSIS
  • 5.4.1 KEY TECHNOLOGIES
    • 5.4.1.1 Powered surgical staplers
    • 5.4.1.2 Endoscopic staplers
  • 5.4.2 COMPLEMENTARY TECHNOLOGIES
    • 5.4.2.1 Tissue sealing and hemostasis
  • 5.4.3 ADJACENT TECHNOLOGIES
    • 5.4.3.1 Laser-based tissue welding
• 5.5 SUPPLY CHAIN ANALYSIS
• 5.6 VALUE CHAIN ANALYSIS
• 5.7 TRADE ANALYSIS
  • 5.7.1 TRADE ANALYSIS OF MEDICAL DEVICE PRODUCTS (HS CODE 9018)
  • 5.7.2 EXPORT DATA FOR LINEAR, CIRCULAR, AND SKIN SURGICAL STAPLERS (HS CODE 9018)
  • 5.7.3 IMPORT DATA FOR LINEAR, CIRCULAR, AND SKIN SURGICAL STAPLERS (HS CODE 9018)
• 5.8 PORTER'S FIVE FORCES ANALYSIS
  • 5.8.1 THREAT OF NEW ENTRANTS
  • 5.8.2 THREAT OF SUBSTITUTES
  • 5.8.3 BARGAINING POWER OF SUPPLIERS
  • 5.8.4 BARGAINING POWER OF BUYERS
  • 5.8.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.9 KEY STAKEHOLDERS & BUYING CRITERIA
  • 5.9.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.9.2 KEY BUYING CRITERIA
• 5.10 REGULATORY LANDSCAPE
  • 5.10.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.10.2 REGULATORY FRAMEWORK
    • 5.10.2.1 North America
      • 5.10.2.1.1 US
      • 5.10.2.1.2 Canada
    • 5.10.2.2 Europe
    • 5.10.2.3 Asia Pacific
      • 5.10.2.3.1 China
      • 5.10.2.3.2 Japan
      • 5.10.2.3.3 India
    • 5.10.2.4 Latin America
      • 5.10.2.4.1 Brazil
      • 5.10.2.4.2 Mexico
    • 5.10.2.5 Middle East
    • 5.10.2.6 Africa
• 5.11 PATENT ANALYSIS
  • 5.11.1 PATENT PUBLICATION TRENDS FOR SURGICAL STAPLERS MARKET
  • 5.11.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
• 5.12 PRICING ANALYSIS
  • 5.12.1 AVERAGE SELLING PRICE OF LINEAR STAPLERS, BY REGION, 2021-2023 (USD)
• 5.13 KEY CONFERENCES & EVENTS, 2024-2025
• 5.14 ECOSYSTEM ANALYSIS
• 5.15 TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
• 5.16 IMPACT OF AI/GEN AI ON SURGICAL STAPLERS MARKET
• 5.17 INVESTMENT & FUNDING SCENARIO
• 5.18 CASE STUDY ANALYSIS
  • 5.18.1 CASE STUDY 1: 50 CASES OF LAPAROSCOPIC INTESTINAL ANASTOMOSIS BY ENDO GIA UNIVERSAL LOADING STAPLERS
  • 5.18.2 CASE STUDY 2: COMPARISON OF SKIN STAPLERS AND SUTURES
  • 5.18.3 CASE STUDY 3: EFFECTIVENESS OF STAPLE LINE REINFORCEMENT
• 5.19 ADJACENT MARKET ANALYSIS
  • 5.19.1 ANASTOMOSIS DEVICES MARKET
  • 5.19.2 BARIATRIC SURGERY DEVICES MARKET
  • 5.19.3 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET
  • 5.19.4 WOUND CARE MARKET

6 SURGICAL STAPLERS MARKET, BY TYPE

• 6.1 INTRODUCTION
• 6.2 LINEAR STAPLERS
  • 6.2.1 PREFERENCE FOR MINIMALLY INVASIVE SURGICAL PROCEDURES TO DRIVE ADOPTION
• 6.3 CIRCULAR STAPLERS
  • 6.3.1 INCREASING PREVALENCE OF COLORECTAL CANCER AND CHRONIC GASTROINTESTINAL DISORDERS TO PROPEL MARKET GROWTH
• 6.4 SKIN STAPLERS
  • 6.4.1 NEED FOR QUICK WOUND CLOSURE IN EMERGENCY ROOMS AND TRAUMA CENTERS TO SPUR MARKET GROWTH
• 6.5 OTHER STAPLERS

7 SURGICAL STAPLERS MARKET, BY TECHNOLOGY

• 7.1 INTRODUCTION
• 7.2 MANUAL STAPLERS
  • 7.2.1 LOW TISSUE REACTIVITY AND REDUCED OPERATING TIME TO DRIVE ADOPTION IN SURGERIES
• 7.3 POWERED STAPLERS
  • 7.3.1 TECHNOLOGICAL ADVANCEMENTS AND PREFERENCE FOR MINIMALLY INVASIVE SURGERIES TO SUPPORT MARKET GROWTH

8 SURGICAL STAPLERS MARKET, BY USABILITY

• 8.1 INTRODUCTION
• 8.2 DISPOSABLE STAPLERS
  • 8.2.1 REDUCED CHANCE OF INFECTION AND NEED FOR MINIMAL MAINTENANCE TO BOOST MARKET GROWTH
• 8.3 REUSABLE STAPLERS
  • 8.3.1 FOCUS ON REDUCING SURGICAL WASTES AND MAXIMIZING CLEANLINESS TO PROPEL MARKET GROWTH

9 SURGICAL STAPLERS MARKET, BY APPLICATION

• 9.1 INTRODUCTION
• 9.2 ABDOMINAL & PELVIC SURGERY
  • 9.2.1 RISING PREVALENCE OF OBESITY AND INCREASING COLORECTAL SURGERIES TO FUEL MARKET GROWTH
• 9.3 GENERAL SURGERY
  • 9.3.1 RISING NUMBER OF GENERAL AND HERNIA SURGERIES TO BOOST ADOPTION OF SURGICAL STAPLERS
• 9.4 CARDIAC & THORACIC SURGERY
  • 9.4.1 INCREASED NEED FOR CARDIAC INTERVENTION, LOBECTOMY, AND WEDGE RESECTION PROCEDURES TO DRIVE MARKET
• 9.5 ORTHOPEDIC SURGERY
  • 9.5.1 FAVORABLE REIMBURSEMENT SCENARIO AND REDUCED POSTOPERATIVE COMPLICATIONS TO SUPPORT MARKET GROWTH
• 9.6 OTHER SURGICAL APPLICATIONS

10 SURGICAL STAPLERS MARKET, BY END USER

• 10.1 INTRODUCTION
• 10.2 HOSPITALS
  • 10.2.1 RISE OF ROBOTIC-ASSISTED AND MINIMALLY INVASIVE SURGERIES TO FUEL MARKET GROWTH
• 10.3 AMBULATORY SURGERY CENTERS
  • 10.3.1 COST-EFFECTIVENESS AND SHORTER PATIENT STAYS TO PROPEL MARKET GROWTH
• 10.4 OTHER END USERS

11 SURGICAL STAPLERS MARKET, BY REGION

• 11.1 INTRODUCTION
• 11.2 NORTH AMERICA
  • 11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 11.2.2 US
    • 11.2.2.1 US to dominate North American surgical staplers market during study period
  • 11.2.3 CANADA
    • 11.2.3.1 Favorable government initiatives and high obesity rates to aid market growth
• 11.3 EUROPE
  • 11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 11.3.2 GERMANY
    • 11.3.2.1 Low cost of surgeries and high healthcare expenditure to support adoption of advanced surgical staplers
  • 11.3.3 UK
    • 11.3.3.1 Growing incidence of cancer and rising geriatric population to boost market growth
  • 11.3.4 FRANCE
    • 11.3.4.1 Favorable reimbursement scenario for minimally invasive procedures to drive market
  • 11.3.5 ITALY
    • 11.3.5.1 Growing focus on research and increasing target patient population to fuel market growth
  • 11.3.6 SPAIN
    • 11.3.6.1 Increasing incidence of cardiovascular diseases to boost adoption of surgical staplers
  • 11.3.7 REST OF EUROPE
• 11.4 ASIA PACIFIC
  • 11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 11.4.2 CHINA
    • 11.4.2.1 Increased incidence of obesity and rising geriatric population to drive market for advanced surgeries
  • 11.4.3 JAPAN
    • 11.4.3.1 Growing prevalence of lifestyle-related diseases and increasing geriatric population to spur market growth
  • 11.4.4 INDIA
    • 11.4.4.1 Better healthcare infrastructure and high government investments to propel market growth
  • 11.4.5 AUSTRALIA
    • 11.4.5.1 Increasing incidence of obesity and rising number of bariatric surgeries to aid market growth
  • 11.4.6 SOUTH KOREA
    • 11.4.6.1 High geriatric population and increased number of surgical procedures to fuel market growth
  • 11.4.7 REST OF ASIA PACIFIC
• 11.5 LATIN AMERICA
  • 11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 11.5.2 BRAZIL
    • 11.5.2.1 High diabetes rates and focus on private-public partnerships for better healthcare facilities to favor market growth
  • 11.5.3 MEXICO
    • 11.5.3.1 Increased focus on medical tourism and developed private healthcare sector to drive market
  • 11.5.4 REST OF LATIN AMERICA
• 11.6 MIDDLE EAST & AFRICA
  • 11.6.1 WELL-DEVELOPED HEALTHCARE INFRASTRUCTURE AND FAVORABLE GOVERNMENT INITIATIVES TO BOOST MARKET GROWTH
  • 11.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
• 11.7 GCC COUNTRIES
  • 11.7.1 HIGH DISPOSABLE INCOME AND INCREASED GOVERNMENT HEALTHCARE EXPENDITURE TO PROPEL MARKET GROWTH
  • 11.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES

12 COMPETITIVE LANDSCAPE

• 12.1 INTRODUCTION
  • 12.1.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN SURGICAL STAPLERS MARKET
• 12.2 REVENUE ANALYSIS, 2019-2023
• 12.3 MARKET SHARE ANALYSIS, 2023
• 12.4 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
  • 12.4.1 STARS
  • 12.4.2 EMERGING LEADERS
  • 12.4.3 PERVASIVE PLAYERS
  • 12.4.4 PARTICIPANTS
  • 12.4.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
    • 12.4.5.1 Company footprint
    • 12.4.5.2 Type footprint
    • 12.4.5.3 Technology footprint
    • 12.4.5.4 Usability footprint
    • 12.4.5.5 Application footprint
    • 12.4.5.6 End-user footprint
    • 12.4.5.7 Region footprint
• 12.5 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
  • 12.5.1 PROGRESSIVE COMPANIES
  • 12.5.2 RESPONSIVE COMPANIES
  • 12.5.3 DYNAMIC COMPANIES
  • 12.5.4 STARTING BLOCKS
  • 12.5.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
• 12.6 COMPANY VALUATION & FINANCIAL METRICS
• 12.7 BRAND/PRODUCT COMPARISON
• 12.8 SURGICAL STAPLERS MARKET: R&D EXPENDITURE
• 12.9 COMPETITIVE SCENARIO
  • 12.9.1 PRODUCT LAUNCHES AND APPROVALS
  • 12.9.2 DEALS
  • 12.9.3 EXPANSIONS

13 COMPANY PROFILES

• 13.1 KEY PLAYERS
  • 13.1.1 MEDTRONIC
    • 13.1.1.1 Business overview
    • 13.1.1.2 Products offered
    • 13.1.1.3 Recent developments
      • 13.1.1.3.1 Deals
    • 13.1.1.4 MnM view
      • 13.1.1.4.1 Right to win
      • 13.1.1.4.2 Strategic choices
      • 13.1.1.4.3 Weaknesses and competitive threats
  • 13.1.2 JOHNSON & JOHNSON SERVICES, INC. (ETHICON, INC.)
    • 13.1.2.1 Business overview
    • 13.1.2.2 Products offered
    • 13.1.2.3 Recent developments
      • 13.1.2.3.1 Product launches
    • 13.1.2.4 MnM view
      • 13.1.2.4.1 Right to win
      • 13.1.2.4.2 Strategic choices
      • 13.1.2.4.3 Weaknesses and competitive threats
  • 13.1.3 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.
    • 13.1.3.1 Business overview
    • 13.1.3.2 Products offered
    • 13.1.3.3 MnM view
      • 13.1.3.3.1 Right to win
      • 13.1.3.3.2 Strategic choices
      • 13.1.3.3.3 Weaknesses and competitive threats
  • 13.1.4 INTUITIVE SURGICAL OPERATIONS, INC.
    • 13.1.4.1 Business overview
    • 13.1.4.2 Products offered
    • 13.1.4.3 Recent developments
      • 13.1.4.3.1 Product approvals
    • 13.1.4.4 MnM view
      • 13.1.4.4.1 Right to win
      • 13.1.4.4.2 Strategic choices
      • 13.1.4.4.3 Weaknesses and competitive threats
  • 13.1.5 3M
    • 13.1.5.1 Business overview
    • 13.1.5.2 Products offered
    • 13.1.5.3 MnM view
      • 13.1.5.3.1 Right to win
      • 13.1.5.3.2 Strategic choices
      • 13.1.5.3.3 Weaknesses and competitive threats
  • 13.1.6 CONMED CORPORATION
    • 13.1.6.1 Business overview
    • 13.1.6.2 Products offered
  • 13.1.7 B. BRAUN SE
    • 13.1.7.1 Business overview
    • 13.1.7.2 Products offered
  • 13.1.8 SMITH+NEPHEW
    • 13.1.8.1 Business overview
    • 13.1.8.2 Products offered
  • 13.1.9 WELFARE MEDICAL LTD.
    • 13.1.9.1 Business overview
    • 13.1.9.2 Products offered
  • 13.1.10 REACH SURGICAL
    • 13.1.10.1 Business overview
    • 13.1.10.2 Products offered
  • 13.1.11 MERIL LIFE SCIENCES PVT. LTD.
    • 13.1.11.1 Business overview
    • 13.1.11.2 Products offered
    • 13.1.11.3 Recent developments
      • 13.1.11.3.1 Expansions
  • 13.1.12 XNY MEDICAL
    • 13.1.12.1 Business overview
    • 13.1.12.2 Products offered
  • 13.1.13 PURPLE SURGICAL
    • 13.1.13.1 Business overview
    • 13.1.13.2 Products offered
  • 13.1.14 FRANKENMAN INTERNATIONAL LTD.
    • 13.1.14.1 Business overview
    • 13.1.14.2 Products offered
  • 13.1.15 LEXINGTON MEDICAL CENTER
    • 13.1.15.1 Business overview
    • 13.1.15.2 Products offered
    • 13.1.15.3 Recent developments
      • 13.1.15.3.1 Product launches
• 13.2 OTHER PLAYERS
  • 13.2.1 NINGBO VERYKIND MEDICAL DEVICE CO., LTD.
  • 13.2.2 WASTON MEDICAL CORPORATION
  • 13.2.3 SUTURE PLANET
  • 13.2.4 DOLPHIN SUTURES
  • 13.2.5 TOUCHSTONE INTERNATIONAL MEDICAL SCIENCE CO., LTD.
  • 13.2.6 NEWGEN SURGICAL
  • 13.2.7 EDGES MEDICARE PRIVATE LIMITED
  • 13.2.8 GOLDEN STAPLER SURGICAL CO., LTD.
  • 13.2.9 VICTOR MEDICAL INSTRUMENTS CO., LTD.
  • 13.2.10 VOLKMANN MEDIZINTECHNIK GMBH

14 APPENDIX

• 14.1 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 14.2 CUSTOMIZATION OPTIONS
• 14.3 RELATED REPORTS
• 14.4 AUTHOR DETAILS